Official SEC submissions

Lakewood-Amedex Biotherapeutics SEC Filings

Direct answer

Lakewood-Amedex Biotherapeutics's latest SEC filing is 8-K.

It was filed on September 29, 2026, and 17 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Lakewood-Amedex Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed: 2026-09-29

Report date: 2026-09-22

CURRENT REPORT

Open SEC document View filing index

S-1

Registration statement

Filed: 2026-09-18

REGISTRATION STATEMENT

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-14

Report date: 2026-06-30

QUARTERLY REPORT

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-08-10

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-08-10

Report date: 2026-09-22

PROXY STATEMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-15

Report date: 2026-07-15

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-17

Report date: 2026-06-15

CURRENT REPORT

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-22

Report date: 2026-03-31

QUARTERLY REPORT

Open SEC document View filing index

Insider transaction

Filed: 2026-05-06

Report date: 2026-04-24

Open SEC document View filing index

S-1

Registration statement

Filed: 2026-05-01

REGISTRATION STATEMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-04-28

Report date: 2026-04-24

CURRENT REPORT

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-04-06

REGISTRATION STATEMENT

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-04-01

REGISTRATION STATEMENT

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-03-11

REGISTRATION STATEMENT

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-02-13

REGISTRATION STATEMENT

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-02-05

REGISTRATION STATEMENT

Open SEC document View filing index

S-1

Registration statement

Filed: 2026-01-09

REGISTRATION STATEMENT

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 17
SEC CIK: 0002079272
Latest filing date: September 29, 2026

Explore related company data

View the Lakewood-Amedex Biotherapeutics company profile View Lakewood-Amedex Biotherapeutics annual financials